Welcome back Honey.
It's distressing to hear about your AML and your current prognosis. You're a fighter and a survivor, but it's obviously been tough, and it's still tough.
I'm not familiar with venetoclax. It goes by trade name Venclexta here in the U.S. and it's often taken with azacitidine, decitabine, or cytarabine. Are they proposing a drug combination like that for you?
The trial mentioned in
this article last month was for patients averaging age 74. From your previous posts I think you are about 50, so that's in your favor.
If they are giving you a poor prognosis compared with successes that you've read about, it could be because of your particular treatment history, or they simply don't want to overpromise. In any case, they are opinions, not guarantees.
Have they discussed any clinical trials or other options with you, or is this clearly the best or only choice for treatment? Have you gotten a second opinion?
I wish that I could be more helpful. I'm sorry that I have questions instead of answers.